Determinants of concentric left ventricular hypertrophy in patients with resistant hypertension: RESIST-POL study

Hypertension Research

Volumn 38, Issue 8, 2015, Pages 545-550

  Dobrowolski, Piotr ^a   Prejbisz, Aleksander ^a   Klisiewicz, Anna ^a   Florczak, Elzbieta ^a   Rybicka, Justyna ^a   Januszewicz, Andrzej ^a   Hoffman, Piotr ^a  

^a INSTITUTE OF CARDIOLOGY   (Poland)

Author keywords

echocardiography; left ventricular concentric hypertrophy; metabolic syndrome; obstructive sleep apnea; resistant hypertension

Indexed keywords

ADULT; AGE; AGED; APNEA HYPOPNEA INDEX; ARTICLE; BIOCHEMICAL ANALYSIS; BLOOD PRESSURE MONITORING; ECHOCARDIOGRAPHY; FEMALE; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HEART LEFT VENTRICLE WALL; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; POLYSOMNOGRAPHY; RESISTANT HYPERTENSION; RISK FACTOR; SLEEP DISORDERED BREATHING; SYSTOLIC BLOOD PRESSURE; BLOOD PRESSURE; COMPLICATION; ECHOGRAPHY; HEART VENTRICLE; HYPERTENSION; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY;

ADULT; BLOOD PRESSURE; ECHOCARDIOGRAPHY; FEMALE; HEART VENTRICLES; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; MALE; MIDDLE AGED; POLYSOMNOGRAPHY; RISK FACTORS; SLEEP APNEA, OBSTRUCTIVE;

EID: 84938771396     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1038/hr.2015.39     Document Type: Article

References (31)

1. Lorell BH,Carabello BA. Left ventricular hypertrophy: pathogenesis, detection, and prognosis Circulation 2000 102 470-479.
2. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Prognostic implications of echocardiographically determined left ventricular mass in the framingham heart study. N Engl J Med 1990; 322: 1561-1566.
3. Verdecchia P, Schillaci G, Borgioni C, Ciucci A, Battistelli M, Bartoccini C, Santucci A, Santucci C, Reboldi G, Porcellati C. Adverse prognostic significance of concentric remodeling of the left ventricle in hypertensive patients with normal left ventricular mass. J Am Coll Cardiol 1995; 25: 871-878.
4. Koren MJ, Devereux RB, Casale PN, Savage DD, Laragh JH. Relation of left ventricu lar mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann Intern Med 1991; 114: 345-352.
5. Acelajado MC, Pisoni R, Dudenbostel T, Dell'Italia LJ, Cartmill F, Zhang B, Cofield SS, Oparil S, Calhoun DA. Refractory hypertension: definition, prevalence, and patient characteristics. J Clin Hypertens (Greenwich) 2012; 14: 7-12.
6. Calhoun DA, Jones D, Textor S, Goff DC, Murphy TP, Toto RD, White A, Cushman WC, White W, Sica D, Ferdinand K, Giles TD, Falkner B, Carey RM. Resistant hypertension: diagnosis, evaluation, and treatment. A scientific statement from the american heart association professional education committee of the council for high blood pressure research. Hypertension 2008; 51: 1403-1419.
7. Kumbhani DJ, Steg PG, Cannon CP, Eagle KA, Smith SC Jr., Crowley K, Goto S, Ohman EM, Bakris GL, Perlstein TS, Kinlay S, Bhatt DL. Resistant hypertension: a frequent and ominous finding among hypertensive patients with atherothrombosis. Eur Heart J 20 12; 34: 1204-1214.
8. Muiesan ML, Salvetti M, Rizzoni D, Paini A, Agabiti-Rosei C, Aggiusti C, Agabiti Rosei E. Resistant hypertension and target organ damage. Hypertens Res 2013; 36: 485-491.
9. Parati G, Ochoa JE, Bilo G, Mattaliano P, Salvi P, Kario K, Lombardi C. Obstructive sleep apnea syndrome as a cause of resistant hypertension. Hypertens Res 2014; 37: 601-613.
10. Nishikawa T, Omura M, Saito J, Matsuzawa Y. The possibility of resistant hypertension during the treatment of hypertensive patients. Hypertens Res 2013; 36: 924-929.
11. Florczak E, Prejbisz A, Szwench-Pietrasz E, Sliwinski P, Bielen P, Klisiewicz A, Michalowska I, Warchol E, Januszewicz M, Kala M, Witkowski A, Wiecek A, Narkiewicz K, Somers VK, Janu szewicz A. Clinical characteristics of patients with resistant hypertension: The resist-pol study. J Hum Hypertens 2013; 27: 678-685.
12. Elliott P, Andersson B, Arbustini E, Bilinska Z, Cecchi F, Charron P, Dubourg O, Kuhl U, Maisch B, McKenna WJ, Monserrat L, Pankuweit S, Rapezzi C, Seferovic P, Tavazzi L, Keren A. Classification of the cardiomyopathies: a position statement from the european society of cardiology working group on myocardial and pericardial diseases. Eur Heart J 2008; 29: 270-276.
13. Ward Flemons W , Buysse D, Redline S, Pack A, Strohl K, Wheatley J, Young T, Douglas N, Levy P, McNicholas W, Fleetham J, White D, Schmidt-Nowarra W, Carley D, Romaniuk J. Sleep-related breathing disorders in a dults: Recommendations for syndrome definition and measurement techniques in clinical research. The report of an american academy of sleep medicine task force. Sleep 1999; 22: 667-689.
14. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, Picard MH, Roman MJ, Seward J, Shanewise JS, Solomon SD, Spencer KT, Sutton MS, Stewart WJ. Chamber Quantification Writing G, American Society of E c hocardiography's G, Standards C, European Association of E. Recommendations for chamber quantification: A report from the american society of echocardiography's guidelines and standards committee and the chamber quantification writing group, developed in conjunction with the european association of echocardiography, a branch of the european society of cardiology. J Am Soc Echocardiogr 2005; 18: 1440-1463.
15. Devereux RB, Reichek N. Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method. Circulation 1977; 55: 613-618.
16. European Society of Hypertension-European Society of Cardiology Guidelines C. 2003 European society of hypertension-European society of cardiology guidelines for the management of arterial hypertension. J Hypertens 2003; 21: 1011-1053.
17. Ganau A, Devereux RB, Roman MJ, de Simone G, Pickeri ng TG, Saba PS, Vargiu P, Simongini I, Laragh JH. Patterns of left ventricular hypertrophy and geometric remodeling in essential hypertension. J Am Coll Cardiol 1992; 19: 1550-1558.
18. Daughe rty SL, Powers JD, Magid DJ, Tavel HM, Masoudi FA, Margolis KL, O'Connor PJ, Selby JV, Ho PM. Incidence and prognosis of resistant hypertension in hypertensive patients. Circulation 2012; 125: 163 5-1642.
19. Wang S, Xue H, Zou Y, Sun K, Fu C, Wang H, Hui R. Left ventricular hypertrophy, abnormal ventricular geometry and relative wall thickness are associated with increased risk of stroke in hyperten sive patients among the han chinese. Hypertens Res 2014; 37: 870-874.
20. Koga S, Ikeda S, Nakata T, Yasunaga T, Maemura K. Effects of nasal continuous positive airway pressure on left ventri cular concentric hypertrophy in obstructive sleep apnea syndrome. Intern Med 2012; 51: 2863-2868.
21. Cioffi G, Russo TE, Stefenelli C, Selmi A, Furlanello F, Cramariuc D, Gerdts E, de Simone G. Severe obstructive sleep apnea elicits concentric left ventricular geometry. J Hypertens 2010; 28: 1074-1082.
22. Chami HA, Devereux RB, Gottdiener JS, Mehra R, Roman MJ, Benja min EJ, Gottlieb DJ. Left ventricular morphology and systolic function in sleep-disordered breathing: The sleep heart health study. Circulation 2008; 117: 2599-2607.
23. de la Sierra A,Banegas JR,Segura J,Gorostidi M,Ruilope LMInvestigators CE. Ambulatory blood pressure monitoring and development of cardiovascular events in high-risk patients included in the spanish abpm registry: The cardiorisc event study J Hypertens 2012 30 713-719.
24. Redon J, Campos C, Narciso ML, Rodicio JL, Pascual JM, Ruilope LM. Prognostic value of ambulatory blood pressure monitoring in refractory hypertension: A prospective study. Hypertension 1998; 31: 712-718.
25. Verdecchia P, Porcellati C, Schillaci G, Borgioni C, Ciucci A, Battistelli M, Guerrieri M, Gatteschi C, Zampi I, Santucci A, Santucci C, Reboldi G et al. Ambulatory blood pressure. An independent predictor of prognosis in essential hypertension. Hypertension 1994; 24: 793-801.
26. Prejbisz A, Florczak E, Klisiewicz A, Dobrowolski P, Janaszek-Sitkowska H, Bielen P, Szwench-Pietrasz E, Warchol-Celinska E, Kolodziejczyk-Kruk S, Janas J, Kabat M, Imiela J, Sliwinski P, Januszewicz A. Relationship between primary aldosteronism and obstructive sleep apnoea, metabolic abnormalities and cardiac structure in patients with resistant hypertension. Endokrynol Pol 2013; 64: 363-367.
27. Mancia G, Bombelli M, Facchetti R, Madotto F, Corrao G, Trevano FQ, Giannattasio C, Grassi G, Sega R. Long-term risk of diabetes, hypertension and left ventricular hypertrophy associated with the metabolic synd Rome in a general population. J Hypertens 2008; 26: 1602-1611.
28. Grandi AM, Maresca AM, Giudici E, Laurita E, Marchesi C, Solbiati F, Nicolini E, Guasti L, Venco A. Metabolic syndrome and morphofunctional characteristics of the left ventricle in clinically hypertensive nondiabetic subjects. Am J Hypertens 2006; 19: 199-205.
29. Mule G, Nardi E, Cottone S, Cusimano P, V olpe V, Piazza G, Mongiovi R, Mezzatesta G, Andronico G, Cerasola G. Influence of metabolic syndrome on hypertension-related target organ damage. J Intern Med 2005; 257: 503-513.
30. Lind L, Andersson PE, Andren B, Hanni A, Lithell HO. Left ventricular hypertrophy in hypertension is associated with the insulin resistance metabolic syndrome. J Hypertens 1995; 13: 433-438.
31. Ho rio T, Miyazato J, Kamide K, Takiuchi S, Kawano Y. Influence of low high-density lipoprotein cholesterol on left ventricular hypertrophy and diastolic function in essential hypertension. Am J Hypertens 2003; 16: 9 38-944.